What's Happening?
Baxter International Inc. is actively recruiting for a Senior Director, Global Clinical Research, to lead evidence-generation strategies within its Infusion Therapies and Technologies (ITP) portfolio. This role is pivotal in transforming medical, clinical,
and business priorities into executable research programs. The Senior Director will be responsible for designing studies that address unmet clinical, scientific, healthcare system, and customer needs, ensuring scientific rigor across all clinical research activities. The position requires an advanced scientific or clinical degree and a minimum of 10 years of experience in clinical research, medical affairs, or evidence generation. The individual will also provide scientific oversight for protocols, statistical plans, and clinical study reports, working closely with Medical Affairs and Clinical Operations to ensure research programs are scientifically sound and operationally feasible. The estimated base salary for this position ranges from $224,000 to $308,000 annually, with potential for additional discretionary bonuses and long-term incentives.
Why It's Important?
This recruitment highlights Baxter International Inc.'s commitment to advancing its ITP portfolio through robust clinical research and evidence generation. The Senior Director's role is crucial for developing and validating new therapies and technologies, which can significantly impact patient care and healthcare delivery. By focusing on scientifically rigorous research programs, Baxter aims to generate meaningful clinical, economic, and operational evidence to support innovation, product development, and regulatory submissions. This strategic investment in leadership for clinical research can lead to the introduction of new medical solutions, potentially improving outcomes for patients relying on infusion therapies and other medical devices. The role also emphasizes the importance of aligning diverse stakeholders, including regulators, payers, and healthcare systems, to ensure that generated evidence is relevant and impactful, ultimately shaping clinical practice and value-based healthcare initiatives.
What's Next?
The immediate next step is the successful recruitment and onboarding of a qualified Senior Director for Global Clinical Research. Once in place, this individual will be tasked with developing and implementing comprehensive evidence-generation strategies for Baxter's ITP portfolio. This will involve designing and overseeing clinical studies, ensuring their scientific rigor and operational feasibility, and collaborating with various internal and external stakeholders. The outcomes of these research programs are expected to inform future product development, regulatory filings, and market adoption of new medical technologies. The company's continued investment in this area suggests a long-term strategy to maintain its competitive edge in the healthcare industry by continuously innovating and providing evidence-based solutions to medical challenges.
Beyond the Headlines
The emphasis on 'implementation science' and 'real-world evidence' in the job description points to a broader trend in the pharmaceutical and medical device industries. There's a growing recognition that clinical trial data alone may not fully capture the effectiveness and impact of interventions in real-world settings. By incorporating these methodologies, Baxter aims to generate more comprehensive evidence that can better inform clinical practice, health policy, and value assessments by payers. This approach also reflects a shift towards patient-centered outcomes and a deeper understanding of how medical innovations integrate into existing healthcare systems. The role's focus on balancing innovation with scientific rigor and adapting to evolving portfolio priorities underscores the dynamic and complex nature of modern medical research and development.













